Blasts More Than 10 Percent of Bone Marrow Nucleated Cells Clinical Trials in Houston, Texas

Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome